Equities

Craneware PLC

CRW:LSE

Craneware PLC

Health CareHealth Care Providers
  • Price (GBX)2,350.00
  • Today's Change-30.00 / -1.26%
  • Shares traded15.94k
  • 1 Year change55.12%
  • Beta0.7708
Data delayed at least 20 minutes, as of Jun 14 2024 16:35 BST.
More ▼

Profile data is unavailable for this security.

About the company

Craneware plc is a United Kingdom company that is engaged in the development, licensing and ongoing support of computer software for the United States healthcare industry. The Company is engaged in automated value cycle solutions, including 340B management, collaborates with United States healthcare providers to plan, execute, and monitor operational and financial performance, so they can deliver quality care to their communities. The Company combines revenue integrity, cost management, 340B performance, and decision enablement into a single, software-as-a-service (SaaS)-based platform. Its solutions include Trisus Pricing Transparency, Trisus Pricing Analyzer, Trisus Chargemaster, Insight Medical Necessity, Trisus Claims Informatics, Trisus Supply, Appeals Services, Trisus Supplies Assistant, Trisus Medication Analytic Solutions, Sentinel, Sentrex, Referral Verification System, Trisus Medication Formulary, Trisus Medication Financial Management, InSight Audit and others.

  • Revenue in GBP (TTM)142.38m
  • Net income in GBP7.38m
  • Incorporated1999
  • Employees734.00
More ▼

Peer analysis

CompanyRevenue (TTM)Net income (TTM)Market capEmployeesMarket Cap /
Employees
Tinexta SpA344.33m19.75m660.69m2.50k660.69m2.50k
Mia Teknoloji AS51.91m26.09m672.78m134.00672.78m134.00
Secunet Security Networks AG332.12m24.59m732.59m1.04k732.59m1.04k
Equasens SA185.42m39.69m736.06m1.24k736.06m1.24k
Crayon Group Holding ASA488.39m-1.03m737.62m4.06k737.62m4.06k
Ovh Groupe SA796.41m-26.13m765.45m2.92k765.45m2.92k
Mensch und Maschine Software SE270.06m25.16m802.93m1.08k802.93m1.08k
Modern Times Group Mtg AB447.71m8.17m808.71m1.02k808.71m1.02k
Nexus AG210.42m21.04m820.47m1.81k820.47m1.81k
Craneware plc142.38m7.38m835.04m734.00835.04m734.00
GB Group plc277.33m-48.58m851.27m1.18k851.27m1.18k
Truecaller AB132.67m42.02m857.62m420.00857.62m420.00
Nagarro SE776.80m45.19m883.24m18.41k883.24m18.41k
Esker SA-84.36bn-84.36bn932.72m1.03k932.72m1.03k
Better Collective A/S281.17m22.28m1.03bn1.68k1.03bn1.68k
Integrafin Holdings PLC138.80m52.30m1.10bn631.001.10bn631.00
Data as of Jun 14 2024. Currency figures normalised to Craneware PLC's reporting currency: UK Pound GBX

Institutional shareholders

44.64%Per cent of shares held by top holders
HolderShares% Held
Liontrust Investment Partners LLPas of 14 May 20243.87m10.97%
Canaccord Genuity Wealth Ltd.as of 03 Aug 20232.66m7.53%
Sanford DeLand Asset Management Ltd.as of 01 Sep 20221.76m4.99%
Aegon Asset Management UK PLCas of 03 Aug 20231.55m4.38%
Octopus Investments Ltd.as of 16 May 20241.44m4.07%
Rathbones Investment Management Ltd.as of 13 Dec 20231.12m3.16%
Amati Global Investors Ltd.as of 03 Aug 20231.09m3.09%
abrdn Investment Management Ltd.as of 03 Aug 20231.08m3.06%
Investec Wealth & Investment Ltd.as of 13 Dec 2023654.01k1.85%
Herald Investment Management Ltd.as of 01 Jun 2024544.00k1.54%
More ▼
Data from 29 Sep 2023 - 31 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.